January 14, 2022 Clinical Research New evidence strongly suggests Epstein-Barr virus (EBV) may help trigger Multiple Sclerosis. Opens the door to further investigation of the mechanism of the disease and if corroborated, lead to vaccines to prevent EBV infection.